| Kaitlin Gilham Brau, MD | |
|
301 N 27th St Ste 20, Norfolk, NE 68701-4457 | |
| (402) 844-8680 | |
| (402) 844-8681 |
| Full Name | Kaitlin Gilham Brau |
|---|---|
| Gender | Female |
| Speciality | Endocrinology |
| Experience | 11 Years |
| Location | 301 N 27th St Ste 20, Norfolk, Nebraska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780024380 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 30757 (Nebraska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Faith Regional Health Services | Norfolk, NE | Hospital |
| Boone County Health Center | Albion, NE | Hospital |
| West Holt Memorial Hospital | Atkinson, NE | Hospital |
| Columbus Community Hospital | Columbus, NE | Hospital |
| Avera St Anthony's Hospital | O' neill, NE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Faith Regional Physician Services Llc | 5193786168 | 162 |
News Archive
Expensive brand-name medications to lower blood pressure are no better at preventing cardiovascular disease than older, generic diuretics, according to new long-term data from a landmark study.Paul Whelton, MB, MD, MSc, reported the results on Aug. 13 at the plenary session of the China Heart Congress and International Heart Forum in Beijing. Whelton is president and CEO of Loyola University Health System and chairman of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heat Attack Trial (ALLHAT), which has examined the comparative value of different blood pressure-lowering medications.
Atrix Laboratories, Inc. has announced today that the company has signed a limited feasibility agreement with Aventis SA (NYSE: AVE) to begin preliminary research on two proprietary Aventis compounds formulated in Atrix's delivery technology, Atrigel®. The current agreement is specific for these compounds in an undisclosed therapeutic area.
Kefir may be a beneficial post-exercise beverage for cancer survivors. It means that cancer survivors can enjoy the nutritional support that milk provides without the potential for significant stomach upset, report researchers in the Journal of Dairy Science.
Researchers in WMG at the University of Warwick have developed a new method that could solve the problem of how to automate support of managing the complexities of care when applying multiple clinical practice guidelines, to patients with more than one medical issue.
› Verified 6 days ago
| Entity Name | Faith Regional Physician Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265489157 PECOS PAC ID: 5193786168 Enrollment ID: O20041022000558 |
News Archive
Expensive brand-name medications to lower blood pressure are no better at preventing cardiovascular disease than older, generic diuretics, according to new long-term data from a landmark study.Paul Whelton, MB, MD, MSc, reported the results on Aug. 13 at the plenary session of the China Heart Congress and International Heart Forum in Beijing. Whelton is president and CEO of Loyola University Health System and chairman of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heat Attack Trial (ALLHAT), which has examined the comparative value of different blood pressure-lowering medications.
Atrix Laboratories, Inc. has announced today that the company has signed a limited feasibility agreement with Aventis SA (NYSE: AVE) to begin preliminary research on two proprietary Aventis compounds formulated in Atrix's delivery technology, Atrigel®. The current agreement is specific for these compounds in an undisclosed therapeutic area.
Kefir may be a beneficial post-exercise beverage for cancer survivors. It means that cancer survivors can enjoy the nutritional support that milk provides without the potential for significant stomach upset, report researchers in the Journal of Dairy Science.
Researchers in WMG at the University of Warwick have developed a new method that could solve the problem of how to automate support of managing the complexities of care when applying multiple clinical practice guidelines, to patients with more than one medical issue.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kaitlin Gilham Brau, MD 301 N 27th St Ste 20, Norfolk, NE 68701-4457 Ph: (662) 808-1324 | Kaitlin Gilham Brau, MD 301 N 27th St Ste 20, Norfolk, NE 68701-4457 Ph: (402) 844-8680 |
News Archive
Expensive brand-name medications to lower blood pressure are no better at preventing cardiovascular disease than older, generic diuretics, according to new long-term data from a landmark study.Paul Whelton, MB, MD, MSc, reported the results on Aug. 13 at the plenary session of the China Heart Congress and International Heart Forum in Beijing. Whelton is president and CEO of Loyola University Health System and chairman of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heat Attack Trial (ALLHAT), which has examined the comparative value of different blood pressure-lowering medications.
Atrix Laboratories, Inc. has announced today that the company has signed a limited feasibility agreement with Aventis SA (NYSE: AVE) to begin preliminary research on two proprietary Aventis compounds formulated in Atrix's delivery technology, Atrigel®. The current agreement is specific for these compounds in an undisclosed therapeutic area.
Kefir may be a beneficial post-exercise beverage for cancer survivors. It means that cancer survivors can enjoy the nutritional support that milk provides without the potential for significant stomach upset, report researchers in the Journal of Dairy Science.
Researchers in WMG at the University of Warwick have developed a new method that could solve the problem of how to automate support of managing the complexities of care when applying multiple clinical practice guidelines, to patients with more than one medical issue.
› Verified 6 days ago
Alan J Spanel, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3901 W Norfolk Ave, Norfolk, NE 68701 Phone: 402-316-4606 Fax: 402-316-3469 | |
Rabih C Fahed, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 110 N 29th St, Suite 101, Norfolk, NE 68701 Phone: 402-644-7550 Fax: 402-644-7551 | |
Nabin Sapkota, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2700 W Norfolk Ave, Norfolk, NE 68701 Phone: 402-371-4880 | |
Dr. Charles Harper Jr., MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1414 N 13th St, Norfolk, NE 68701 Phone: 402-316-4606 | |
Dr. David A Dudley, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3901 W Norfolk Ave Ste D, Norfolk, NE 68701 Phone: 402-844-8000 Fax: 402-844-8047 | |
Punya Hari Dahal, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2700 W Norfolk Ave, Norfolk, NE 68701 Phone: 402-378-4880 | |
Dr. Brian Jay Keegan, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2700 W Norfolk Ave, Attn:hospitalists, Norfolk, NE 68701 Phone: 402-371-4880 |